Johnson & Johnson (NYSE:JNJ) reported new long-term data indicating that its therapy TREMFYA (guselkumab) continued to ...

Johnson & Johnson (NYSE: JNJ) today announced new long-term data from the QUASAR long-term extension (LTE) study showing that TREMFYA® (guselkumab) sustained clinical, endoscopic, and histologic ...

Crohn’s and UC affect the GI tract differently. Crohn’s impacts the whole tract, while UC is limited to the colon. Learn the ...

Microscopic colitis is a lifelong condition that causes symptoms such as diarrhea and abdominal pain. It is a type of inflammatory bowel disease (IBD). While there is no cure for microscopic colitis, ...

GRAND RAPIDS, Mich. — If the Crohn’s & Colitis Foundation has anything to say about it, a cure for Crohn’s, Ulcerative Colitis, and many other conditions could be right around the corner. And for ...

Add Yahoo as a preferred source to see more of our stories on Google. “Debilitating digestive issues dominated my life because I couldn’t go longer than a half hour without going to the bathroom,” ...

Doctors usually prescribe antibiotics for certain types of colitis, such as ulcerative colitis and ischemic colitis. While antibiotics help with symptoms, there may be some adverse effects. Colitis ...

What Is Infusion for Ulcerative Colitis? If your doctor has recommended infusion therapy, this is probably because standard treatment hasn’t helped relieve symptoms caused by moderate-to-severe ...

Researchers at Örebro University have identified blood markers that can indicate who is at risk of developing ulcerative ...

Researchers at örebro University have identified blood markers that can indicate who is at risk of developing ulcerative ...

Johnson & Johnson has reported new long‑term results from the QUASAR long‑term extension study, showing that Tremfya (guselkumab) sustained clinical, endoscopic and histologic outcomes through week ...